News
Home/ News
(Filtering posts by category: Innovations) - Remove filter
Fashion thrives on collaboration— and while collaborations offer huge creative and commercial potential, they also come with risks—especially when it comes to intellectual property (IP).
Indonesia isn’t just our closest neighbour — it’s ASEAN’s largest economy, home to more than 270 million people, and one of the fastest-transforming markets in the world. Indonesia’s rise offers an unprecedented opportunity for Australian businesses.
Electric vehicles (EVs) are becoming one of the fastest-growing areas for intellectual property filings. For businesses innovating in EVs, batteries, or related technologies, protecting your IP is essential to compete in this rapidly growing market.
The rapid growth of artificial intelligence (AI) has triggered a major debate in Australia — especially over whether copyright-protected material can be used without permission to train AI systems. Creative and media industries are among the loudest voices calling for stronger safeguards.
When you're building a business, some of your most valuable assets aren’t physical — they’re ideas, plans, know-how, and insider knowledge. This type of information is known as confidential information, and it plays a key role in protecting your competitive edge. But how do you keep it safe?
If you’ve ever created something original — a design, a song, a video, an artwork, even a piece of social media content — you already have something worth protecting. That’s where copyright comes in.
What was once futuristic is now just the new frontier. And for artists, developers, and brands, the question is no longer if you’ll need to adopt immersive formats, but how you’ll do it better than the rest.
When you open Google Maps to find a coffee shop, plan your drive, or check traffic, you probably don’t think about patents. But patents are a big part of why Google Maps is the leader in navigation technology — and why it’s so hard for competitors to catch up.
In a recent decision that has implications for pharmaceutical patent strategy in Australia, the Federal Court has both clarified and complicated the rules around patent term extensions (PTEs).
